- Cat. No.
- A11299
Avibactam
Synonyms: NXL-104 free acid
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Beta-lactamase inhibitors block the bacterial enzymes that hydrolyze the β-lactam ring. Enzymatic destruction of penicillin by bacteria was described in 1940, and the structural classes of these enzymes were set out in 1980. Clavulanic acid, reported in 1977 from Streptomyces clavuligerus, is a β-lactam that inactivates serine β-lactamases, as do sulbactam and tazobactam. Avibactam and durlobactam sodium belong to the diazabicyclooctanes, a non-β-lactam scaffold that forms a reversible covalent adduct with the enzyme. The list also holds β-lactam substrates such as ceftazidime and cephalothin sodium, which serve as reference compounds when hydrolysis by different enzymes is compared. Compounds for other microbial targets appear under the sibling category Anti-infectives.
Synonyms: NXL-104 free acid
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.
Synonyms: CP45899 sodium
Sulbactam sodium is a competitive, irreversible beta-lactamase inhibitor, primarily targeting beta-lactamases in bacterial pathogens. It exhibits significant antimicrobial activity against multidrug-resistant Acinetobacter calcoaceticus–Acinetobacter baumannii (Acb) complex, making it a valuable compound for research into antibiotic resistance. This reagent is useful for studying mechanisms of resistance and developing novel therapeutic strategies in the fight against MDR infections.
Clavulanic acid is a mechanism-based β-lactamase inhibitorcombined with penicillin group antibiotics to overcome certain types of antibiotic resistance.
Durlobactam, also known as ETX2514, is a beta-lactamase inhibitor drug candidate.
Synonyms: CL-298741; YTR-830H
Tazobactam is a potent β-lactamase inhibitor that enhances the effectiveness of β-lactam antibiotics by preventing the hydrolysis of the β-lactam ring. This compound exhibits significant antibacterial activity, making it a valuable tool in the study of bacterial resistance mechanisms. Tazobactam is particularly useful in research related to pneumonia and other infections caused by β-lactamase-producing pathogens.
Synonyms: Cefalotin
Cephalothin sodium is a semisynthetic, beta-lactam, first-generation cephalosporin antibiotic with bactericidal activity.
Tazobactam sodium is a beta-lactamase inhibitor that enhances the efficacy of beta-lactam antibiotics by preventing the breakdown of their molecular structure. It is commonly used in combination with ceftolozane to extend its antimicrobial activity against extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae and certain Bacteroides species. This compound is valuable in research applications focused on combating antibiotic resistance and studying the mechanisms of beta-lactamase enzymes.
Synonyms: NXL-104
Avibactam sodium (NXL-104) is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively.
Synonyms: GR20263
Ceftazidime (GR20263), an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases.
Synonyms: Enmetazobactam
AAI-101, also known as Enmetazobactam, is a beta lactamase inhibitor potentially for the treatment of multi-drug resistant gram-negative bacterial infections.
Synonyms: WCK-5107
Zidebactam (WCK-5107) is a potent β-lactamase inhibitor. Zidebactam also is a penicillin-binding protein2 (PBP2) inhibitor with an IC50 of 0.26 μg/mL.
VNRX-5133 is a cyclic boronate β-lactamase inhibitor.
Synonyms: OP0595 free acid; OP 0595
Nacubactam (OP0595 free acid) is a potent non-β-lactam-β-lactamase inhibitor with activity against class A and class C β-lactamases.
Taniborbactam is a potent inhibitor of β-lactamase, with IC50s of
Synonyms: RPX7009
Vaborbactam is a cyclic boronic acid pharmacophore β-lactamase inhibitor.
BRL-42715 is a potent inhibitor of a broad range of bacterial beta-lactamases (β-lactamase) .
beta-lactamase-IN-1 targets Neisseria gonorrhoeae infection which comprises administering to a subject in need thereof novel Tricyclic nitrogen containing compounds and corresponding pharmaceutical compositions as described herein.
Synonyms: MK-7655
Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes.
Synonyms: WCK-5107 sodium salt; WCK5107
Zidebactam sodium salt (WCK-5107 sodium salt) is a potent β-lactamase inhibitor. Zidebactam also is a penicillin-binding protein2 (PBP2) inhibitor with an IC50 of 0.26 μg/mL.
Synonyms: CP-70429
Sulopenem (CP-70429) is an orally active, potent inhibitor of beta-lactamase. Sulopenem is a parenteral penem antibiotic with broad-spectrum activities against Gram-positive and Gram-negative bacteria.
Synonyms: Kalamycin; U-19718
Kalafungin is a β-lactamase inhibitor derived from marine Streptomyces, exhibiting an IC50 value of 225.37 μM. This compound demonstrates potent antimicrobial activity against a range of pathogenic fungi, yeasts, and protozoa, as well as significant effects on gram-positive bacteria like Staphylococcus aureus. Additionally, Kalafungin shows moderate activity against select gram-negative bacteria, making it a valuable tool for research in antibiotic resistance and microbial pathogenesis.
Metallo-β-lactamase-IN-5 is a potent inhibitor of metallo-β-lactamases (MBLs), specifically targeting NDM-1 and VIM-1 enzymes. This compound demonstrates significant biological activity with an IC50 of 45 μg/mL against human umbilical vein endothelial cells (HUVECs). Additionally, the combination of Metallo-β-lactamase-IN-5 with Imipenem leads to synergistic antimicrobial effects, making it a valuable reagent for research into antibiotic resistance and potential therapeutic strategies.
RDR 02308 is a β-lactamase inhibitor that targets the TLR4-MyD88 signaling pathway. This compound effectively inhibits the activity of full-length β-lactamase, providing a valuable tool for studies related to antibiotic resistance. Its mechanism of action makes it suitable for research applications focused on bacterial infections and the development of novel therapeutic strategies.
Nitrocefin is a chromogenic substrate specifically targeting β-lactamase enzymes. It displays a characteristic color shift from yellow to red upon hydrolysis of the β-lactam ring, enabling visual quantification of β-lactamase activity. This reagent is widely utilized in studies of enzyme inhibition and the development of β-lactamase-resistant antibiotics.